Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu

Faculty

John Bennett, M.D.

John M. Bennett, MDJohn M. Bennett, M.D., Professor Emeritus of Medicine, Pathology, and Laboratory Medicine. Dr. Bennett is an internationally renowned morphologist who has been instrumental in almost every aspect of marrow morphology.  He played a critical role in the development of the FAB system for classification of AML and MDS, and continues as a contributor to the WHO system.  In June 2013, Dr. Bennett completed his 20 year’s as an Editor-in-chief of “Leukemia Research”.  Dr. Bennett also maintains a very substantial role in clinical conferences, is daily available for consultation, is directly involved in resident/fellow education.  He also maintains a large consultation practice, including centralized review for clinical trials, which forms a great resource for fellow education.

Richard Burack, M.D., Ph.D.

Director of Flow Cytometry Laboratory, Protein Electrophoresis Laboratory,
and the Molecular Genetic Pathology Unit

Richard BurackRichard Burack, M.D., Ph.D., Associate Professor. Director of Hematopathology Unit, Flow Cytometry Laboratory, Protein Electrophoresis Laboratory, and the Molecular Genetic Pathology Unit. Dr. Burack initiated this fellowship program in 2007 after arriving from Washington University in St. Louis where he trained and ultimately ran the hematopathology fellowship there.  Dr. Burack’s clinical practice is focused on the diagnosis of hematopoietic malignancies. He has a particular interest in the application of molecular methods to diagnosis of lymphoma.

Andrew Evans, M.D., Ph.D.

Associate Professor and Director of Hematopathology

Andrew G. Evans, MD, PhDAndrew Evans, M.D., Ph.D., Assistant Professor, Pathology and Laboratory Medicine. Dr. Evans joined the faculty in 2013 after completing his training in Boston at Brigham and Women’s Hospital, Harvard Medical School, and the Dana Farber Cancer Institute where he served as Chief Resident in Anatomic Pathology and completed his fellowship in Hematopathology. Dr. Evans earned his MD and PhD in Immunology and Molecular Pathogenesis from Emory University’s School of Medicine. Dr. Evans contributes to all aspects of the clinical hematopathology service, and his research interests include the immunology and pathobiology of lymphoproliferative disorders.

Archibald Perkins, Ph.D.

Archibald Perkins M.D., Ph.D.Archibald S. Perkins M.D., Ph.D., Professor. Dr. Perkins joined the faculty in July 2007 having been on the faculty of the Dept. of Pathology of Yale University for 15 years. In addition to signout responsibilities, Dr. Perkins has a substantial research program dedicated to the understanding of EVI1 (3q26) lesions in myeloid malignancies.

Tony YW Yeung, M.D., Ph.D.

Tony YW Yeung, M.D., Ph.D.Tony YW Yeung, M.D., Ph.D., Assistant Professor. Dr. Yeung joined the URMC faculty in 2019. Prior to this, he completed residency at Beth Israel Deaconess Medical Center, followed by time spent doing research in chemotherapy resistance at Harvard Medical School and University Health Network Toronto. Yeung did his fellowship in hematopathology at Vanderbilt University. His current research interests include Myelodysplastic Syndrome, therapy response, and image cytometry.